Macular Support Formula

Pure Encapsulations

$102.80
(No reviews yet) Write a Review
SKU:
PUR-MACU4-1
Availability:
Usually Ships in 48 to 72 Hours
Minimum Purchase:
1 unit
Already Registered?
How to Gain Access to Store?

Macular Support Formula by Pure Encapsulations 

Macular Support Formula by Pure Encapsulations supports macula health and protection, helping to maintain the health of the optical lens and promoting the integrity and density of the macular pigment. It may help moderate visual fatigue and improve light-to-dark adjustments. Featuring botanicals and antioxidants in standardized amounts, it is made with high-quality vegetarian ingredients backed by verifiable science.*
 
Recommendation:
Pure Encapsulations suggests taking 2 capsules daily with a meal, or as directed by a healthcare professional.
 
Serving Size: 2 capsules
Servings Per Container: 30 or 60
 
Amount Per Serving:
Vitamin A (as beta carotene)    7,500 mcg
Vitamin C (as ascorbic acid)    800 mg   
N-acetyl-l-cysteine (free-form)  250 mg  
Setria® glutathione (reduced)   50 mg  
Bilberry (vaccinium myrtillus) extract (fruit)   80 mg  
 (standardized to contain 25% anthocyanosides)
Grape (vitis vinifera) extract (seed)  50 mg   
 (standardized to 92% polyphenols)
FloraGLO® lutein   10 mg   
Zeaxanthin   2 mg  
Proprietary mixed carotenoid blend  (as lycopene, lutein and zeaxanthin)  1,445 mcg  
 
Other Ingredients: ascorbyl palmitate, vegetarian capsule (cellulose, water)

Caution: If you are pregnant or lactating, have any health condition or are taking any medication, consult your health professional before use.
 
Storage: Store in a cool, dry place.
 
Trademarks:
®FloraGLO is a registered trademark of Kemin Industries, Inc.Zeaxanthin is sourced from OPTISHARP® Natural brand. 
OPTISHARP® Natural is a trademark of DSM.
Setra® is a registered trademark of KYOWA HAKKO BIO Co. , Ltd. 
 

Pure Encapsulations’ logo, text, graphics, and photo images are the property of Société des Produits Nestlé S.A. and are used with permission. Copyright © 2021.